Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

廣貫堂

日本化学工業

Carna Biosciences

Nippon Shikizai

Kawaguchi Chemical Industry

RaQualia Pharma

Chiome Bioscience

NIPPON SEIRO

シンバイオ製薬

本州化学工業

CHISSO

KAWAKAMI PAINT MFG.

関東電化工業

Sosei Group

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

日本アビオニクス

日本アビオニクス

日本アビオニクス

Renesas Electronics

日本セラミック

Financial Indicator Details: NIPPON SEIRO+シンバイオ製薬 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: NIPPON SEIRO+シンバイオ製薬 (Annual )

Non-Consolidated :Indicator Non-Consolidated

Profitability	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Net profit margin	1.59%	-88.64%
C/F margin	-6.95%	-84.80%
ROA	2.09%	-31.49%
ROE	5.66%	-35.37%
Growth	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Capital adequacy	36.93%	89.03%
Liquidity ratio	129.76%	905.66%
C/F ratio current liabilities	-439.11%	-36.09%
Quick ratio	48.20%	783.27%
Stability	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Equity growth	2.62%	-25.82%
Sales growth	8.30%	3.87%
Net profit growth	-63.11%	17.63%
Operating C/F growth	-204.18%	20.05%
Turnover	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Inventory turnover	86.73day	30.78day
Receivables turnover	45.68day	27.64day
Payable turnover	9.42day	61.56day
Working capita turnover	122.99day	-3.13day
Market Value growth	-16.78%	0
Dividend Yield	5.80%	0
PER	8.14%	0
PBR	0.46%	0
PCFR	-1.87%	0
PSR	0.13%	0

View the financial indicators, more.

Financial Indicator Details: NIPPON SEIRO+シンバイオ製薬

Non-Consolidated :Indicator Non-Consolidated

Indicator	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Profitability
Net profit margin	4.69%	-111.79%
C/F margin	7.23%	-110.20%
ROA	5.52%	-28.99%
ROE	15.76%	-31.85%
Recurring margin	7.96%	-111.31%
EBIT margin	8.43%	-111.63%
EBITDA margin	11.29%	-111.19%
NOPAT margin	5.06%	-66.97%
Sales SG rates	85.18%	65.01%
Sales SG&A rates	6.44%	144.80%
Sales R&D expenses rates	-	-
Sales depreciation rates	2.85%	0.43%
Capital expenditures net sales ratio	-1.27%	-0.07%
Indicator	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Growth
Growth rate of cash	39.74%	96.96%
Equity growth	20.94%	61.76%
Total assets growth	14.99%	70.21%
Sales growth	13.33%	29.79%
Net profit growth	14.64%	-227.56%
Operating C/F growth	-17.04%	-175.07%
Recurring profit growth	16.84%	-228.17%
EBIT growth	12.29%	-228.51%
EBITDA growth	13.03%	-230.60%
NOPAT growth	12.29%	-228.51%
Operating expenses growth	-	-
Indicator	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Stability
Capital adequacy	35.06%	91.02%
Liquidity ratio	118.44%	1,111.64%
C/F ratio current liabilities	515.42%	-31.13%
Quick ratio	46.23%	731.11%
Fixed ratio	129.82%	0.26%
D/E ratio	85.83%	-
Loan to Value Ratio	30.10%	-
Business investment C/F ratio	-17.55%	0.06%
Liabilities with interest growth	-13.50%	-
Indicator	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Turnover
Cash turnover	14.91day	884.12day
Receivables turnover	48.01day	31.49day
Inventory turnover	93.19day	40.23day
Fixed assets turnover	141.21day	3.37day
Total asset turnover	310.15day	1,407.26day
Payable turnover	47.97day	59.91day
Capital turnover	11.04day	1,168.42day
Equity turnover	108.77day	1,280.99day
Working capita turnover	93.23day	11.81day
Indicator	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Balance sheet
Cash etc.	¥ 1 B	¥ 2 B
Accounts receivable-trade	¥ 4 B	¥ 5 M
Other Current Assets	¥ 11 B	¥ 1 B
Current Assets	¥ 12 B	¥ 4 B
Tangible Assets	¥ 14 B	¥ 21 M
Intangible Assets	¥ 35 M	¥ 772 K
Investment etc.	¥ 435 M	¥ 27 M
Total Assets	¥ 27 B	¥ 4 B
Current Liabilities	¥ 11 B	¥ 177 M
Fixed Liabilities	¥ 6 B	¥ 1 M
Liabilities with interest	¥ 10 B	-
Net Assets	¥ 9 B	¥ 4 B
Capital stock	¥ 1 B	¥ 3 B
Capital surplus etc.	¥ 7 B	¥ 372 M
Liabilities and net assets	¥ 27 B	¥ 4 B
Indicator	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Income statement
Sales	¥ 32 B	¥ 1 B
Cost of Sales	¥ 27 B	¥ 238 M
Gross profit	¥ 4 B	¥ 1 B
Other income	¥ 312 M	¥ 12 M
SG&A	¥ 2 B	¥ 1 B
Other expenses	¥ 1 B	¥ 42 M
Net income	¥ 1 B	¥ -642 M
Operating income	¥ 2 B	¥ -612 M
Ordinary Income	¥ 2 B	¥ -638 M
EBITDA	¥ 3 B	¥ -633 M
Income before income taxes	¥ 2 B	¥ -638 M
Depreciation	¥ 918 M	¥ 6 M
R&D expenses	-	-
Income taxes	¥ 1 B	¥ 3 M
Indicator	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Cash flow statement
Operating CF	¥ 3 B	¥ -753 M
Investment CF	¥ -961 M	¥ -115 M
Financial CF	¥ -2 B	¥ 662 M
Foreign Exchange Effects	¥ -7 M	¥ 1 M
Net Change in Cash	¥ 157 M	¥ -205 M
Free CF	¥ 2 B	¥ -869 M
Capital expenditures	¥ -1 B	¥ -14 M
Cash dividends paid	¥ -179 M	-
Repayment loans	¥ -1 B	-
Indicator	NIPPON SEIRO (2012-12-31)	シンバイオ製薬 (2012-12-31)
Shareowners' equity
Issuance of new shares	-	¥ 665 M
Dividends from surplus	¥ -179 M	-
Net income	¥ 1 B	¥ -642 M
Purchase of treasury stock	¥ -529 M	-
Other Change in Stockholders Equity	¥ -1 M	¥ -1 K
Other Change in Net Assets	¥ -6 M	¥ 6 M
Net Change in Net Assets	¥ 801 M	¥ 29 M

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: NIPPON SEIRO  シンバイオ製薬 

Statement Type

Annual : NIPPON SEIRO+シンバイオ製薬

First quarter : NIPPON SEIRO+シンバイオ製薬

Second quarter : NIPPON SEIRO+シンバイオ製薬

Third quarter : NIPPON SEIRO+シンバイオ製薬

Analysis Menu

Outline : NIPPON SEIRO+シンバイオ製薬

Statement : NIPPON SEIRO+シンバイオ製薬

Rating : NIPPON SEIRO+シンバイオ製薬

Indicator : NIPPON SEIRO+シンバイオ製薬

Download : NIPPON SEIRO+シンバイオ製薬

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo中央区 - EDIUNET Prefectures

Tokyo港区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
NIPPON SEIRO	5010	TSE 2st	Chemicals	12	Annual	BB
シンバイオ製薬	4582	OSE JASDAQ	Chemicals	12	Annual	BB

Related Company

本州化学工業 (Sales ¥ 13 B)

関東電化工業 (Sales ¥ 30 B)

Carna Biosciences (Sales ¥ 464 M)

Chiome Bioscience (Sales ¥ 324 M)

日本化学工業 (Sales ¥ 27 B)

Nippon Shikizai (Sales ¥ 6 B)

Sosei Group (Sales -)

廣貫堂 (Sales ¥ 10 B)

シンバイオ製薬 (Sales ¥ 1 B)

KAWAKAMI PAINT MFG. (Sales ¥ 5 B)

Kawaguchi Chemical Industry (Sales ¥ 6 B)

RaQualia Pharma (Sales ¥ 28 M)

NIPPON SEIRO (Sales ¥ 40 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .